Back

Relation of right ventricular function abnormalities to the presence of pulmonary hypertension in heart failure with preserved ejection fraction. Insights from invasive pressure-volume analysis.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Chronic heart failure – Pathophysiology and mechanisms Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Karl-Philipp Rommel

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

15 More presentations in this session

Presentation thumbnail
The effect of statin on mortality in patients with heart failure with preserved ejection fraction without coronary artery disease -a report from the JASPER-study-
Doctor K. Marume (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Significance of left ventricular global longitudinal strain assessment in patients with preserved ejection fraction after acute myocardial infarction
Doctor K. Batmyagmar (Ulaanbaatar, MN)
Presentation thumbnail
Combined exercise stress echocardiography and cardiopulmonary exercise test in assessment of diastolic function in patients successfully treated with primary percutaneous coronary intervention
Professor I. Nedeljkovic (Belgrade, RS)
Abstract
Presentation thumbnail
HDAC inhibition rescues cardiac and pulmonary function in a feline model of HFpEF
Associate Professor M. Wallner (Graz, AT)
Abstract
Presentation thumbnail
Prognostic impact of left atrial function in heart failure with preserved ejection fraction
Doctor R. Schoenbauer (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Chronic heart failure – Pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources